ε‐poly‐L‐lysine‐modified polydopamine nanoparticles for targeted photothermal therapy of drug‐resistant bacterial keratitis

Abstract Bacterial keratitis can lead to intraocular infection and even blindness without prompt and potent treatments. Currently, clinical abuse of antibiotics encouraged the evolution of resistant bacteria. Conventional antibiotic eye drops based keratitis treatment has been heavily restricted due...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenjie Fan, Haijie Han, Zhouyu Lu, Yue Huang, Yin Zhang, Yaoyao Chen, Xiaobo Zhang, Jian Ji, Ke Yao
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Bioengineering & Translational Medicine
Subjects:
Online Access:https://doi.org/10.1002/btm2.10380
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846161773137231872
author Wenjie Fan
Haijie Han
Zhouyu Lu
Yue Huang
Yin Zhang
Yaoyao Chen
Xiaobo Zhang
Jian Ji
Ke Yao
author_facet Wenjie Fan
Haijie Han
Zhouyu Lu
Yue Huang
Yin Zhang
Yaoyao Chen
Xiaobo Zhang
Jian Ji
Ke Yao
author_sort Wenjie Fan
collection DOAJ
description Abstract Bacterial keratitis can lead to intraocular infection and even blindness without prompt and potent treatments. Currently, clinical abuse of antibiotics encouraged the evolution of resistant bacteria. Conventional antibiotic eye drops based keratitis treatment has been heavily restricted due to the lack of bactericidal efficiency and easy induction of bacterial resistance. Hence, developing an effective treatment strategy for bacterial keratitis is of great significance. In this work, we investigated ε‐poly‐l‐lysine (EPL)‐modified polydopamine (PDA) nanoparticles (EPL@PDA NPs)‐mediated antibacterial photothermal therapy (aPTT), to cope with methicillin‐resistant Staphylococcus aureus (MRSA)‐induced keratitis. The surface modification of cationic peptide EPL enables EPL@PDA NPs to specifically target negatively charged MRSA and induces local hyperthermia to kill the bacteria under low ambient temperature. Under near‐infrared (NIR) irradiation, the sterilization efficiency of EPL@PDA NPs suspension for MRSA in vitro was up to 99.96%. The EPL@PDA‐mediated aPTT presented potent antibacterial efficacy in treating MRSA‐induced keratitis with little corneal epithelial cytotoxicity and good biocompatibility. In conclusion, the bacterial‐targeting aPTT platform in this work provides a prospective method for the management of MRSA‐induced refractory bacterial keratitis.
format Article
id doaj-art-af14b47bc019417aa58b74aa4da02452
institution Kabale University
issn 2380-6761
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Bioengineering & Translational Medicine
spelling doaj-art-af14b47bc019417aa58b74aa4da024522024-11-21T05:16:03ZengWileyBioengineering & Translational Medicine2380-67612023-01-0181n/an/a10.1002/btm2.10380ε‐poly‐L‐lysine‐modified polydopamine nanoparticles for targeted photothermal therapy of drug‐resistant bacterial keratitisWenjie Fan0Haijie Han1Zhouyu Lu2Yue Huang3Yin Zhang4Yaoyao Chen5Xiaobo Zhang6Jian Ji7Ke Yao8Eye Center, the Second Affiliated Hospital, School of Medicine Zhejiang University Hangzhou People's Republic of ChinaEye Center, the Second Affiliated Hospital, School of Medicine Zhejiang University Hangzhou People's Republic of ChinaEye Center, the Second Affiliated Hospital, School of Medicine Zhejiang University Hangzhou People's Republic of ChinaMOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering Zhejiang University Hangzhou People's Republic of ChinaEye Center, the Second Affiliated Hospital, School of Medicine Zhejiang University Hangzhou People's Republic of ChinaEye Center, the Second Affiliated Hospital, School of Medicine Zhejiang University Hangzhou People's Republic of ChinaEye Center, the Second Affiliated Hospital, School of Medicine Zhejiang University Hangzhou People's Republic of ChinaMOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering Zhejiang University Hangzhou People's Republic of ChinaEye Center, the Second Affiliated Hospital, School of Medicine Zhejiang University Hangzhou People's Republic of ChinaAbstract Bacterial keratitis can lead to intraocular infection and even blindness without prompt and potent treatments. Currently, clinical abuse of antibiotics encouraged the evolution of resistant bacteria. Conventional antibiotic eye drops based keratitis treatment has been heavily restricted due to the lack of bactericidal efficiency and easy induction of bacterial resistance. Hence, developing an effective treatment strategy for bacterial keratitis is of great significance. In this work, we investigated ε‐poly‐l‐lysine (EPL)‐modified polydopamine (PDA) nanoparticles (EPL@PDA NPs)‐mediated antibacterial photothermal therapy (aPTT), to cope with methicillin‐resistant Staphylococcus aureus (MRSA)‐induced keratitis. The surface modification of cationic peptide EPL enables EPL@PDA NPs to specifically target negatively charged MRSA and induces local hyperthermia to kill the bacteria under low ambient temperature. Under near‐infrared (NIR) irradiation, the sterilization efficiency of EPL@PDA NPs suspension for MRSA in vitro was up to 99.96%. The EPL@PDA‐mediated aPTT presented potent antibacterial efficacy in treating MRSA‐induced keratitis with little corneal epithelial cytotoxicity and good biocompatibility. In conclusion, the bacterial‐targeting aPTT platform in this work provides a prospective method for the management of MRSA‐induced refractory bacterial keratitis.https://doi.org/10.1002/btm2.10380drug‐resistant bacteriakeratitisphotothermal therapypolydopamineε‐poly‐l‐lysine
spellingShingle Wenjie Fan
Haijie Han
Zhouyu Lu
Yue Huang
Yin Zhang
Yaoyao Chen
Xiaobo Zhang
Jian Ji
Ke Yao
ε‐poly‐L‐lysine‐modified polydopamine nanoparticles for targeted photothermal therapy of drug‐resistant bacterial keratitis
Bioengineering & Translational Medicine
drug‐resistant bacteria
keratitis
photothermal therapy
polydopamine
ε‐poly‐l‐lysine
title ε‐poly‐L‐lysine‐modified polydopamine nanoparticles for targeted photothermal therapy of drug‐resistant bacterial keratitis
title_full ε‐poly‐L‐lysine‐modified polydopamine nanoparticles for targeted photothermal therapy of drug‐resistant bacterial keratitis
title_fullStr ε‐poly‐L‐lysine‐modified polydopamine nanoparticles for targeted photothermal therapy of drug‐resistant bacterial keratitis
title_full_unstemmed ε‐poly‐L‐lysine‐modified polydopamine nanoparticles for targeted photothermal therapy of drug‐resistant bacterial keratitis
title_short ε‐poly‐L‐lysine‐modified polydopamine nanoparticles for targeted photothermal therapy of drug‐resistant bacterial keratitis
title_sort ε poly l lysine modified polydopamine nanoparticles for targeted photothermal therapy of drug resistant bacterial keratitis
topic drug‐resistant bacteria
keratitis
photothermal therapy
polydopamine
ε‐poly‐l‐lysine
url https://doi.org/10.1002/btm2.10380
work_keys_str_mv AT wenjiefan epolyllysinemodifiedpolydopaminenanoparticlesfortargetedphotothermaltherapyofdrugresistantbacterialkeratitis
AT haijiehan epolyllysinemodifiedpolydopaminenanoparticlesfortargetedphotothermaltherapyofdrugresistantbacterialkeratitis
AT zhouyulu epolyllysinemodifiedpolydopaminenanoparticlesfortargetedphotothermaltherapyofdrugresistantbacterialkeratitis
AT yuehuang epolyllysinemodifiedpolydopaminenanoparticlesfortargetedphotothermaltherapyofdrugresistantbacterialkeratitis
AT yinzhang epolyllysinemodifiedpolydopaminenanoparticlesfortargetedphotothermaltherapyofdrugresistantbacterialkeratitis
AT yaoyaochen epolyllysinemodifiedpolydopaminenanoparticlesfortargetedphotothermaltherapyofdrugresistantbacterialkeratitis
AT xiaobozhang epolyllysinemodifiedpolydopaminenanoparticlesfortargetedphotothermaltherapyofdrugresistantbacterialkeratitis
AT jianji epolyllysinemodifiedpolydopaminenanoparticlesfortargetedphotothermaltherapyofdrugresistantbacterialkeratitis
AT keyao epolyllysinemodifiedpolydopaminenanoparticlesfortargetedphotothermaltherapyofdrugresistantbacterialkeratitis